SF5
CAS No. 34634-22-5
SF5 ( SF-5; SF 5; 2,2-Diphenylethylisothiocyanate )
Catalog No. M27794 CAS No. 34634-22-5
SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 393 | Get Quote |
|
10MG | 581 | Get Quote |
|
25MG | 888 | Get Quote |
|
50MG | 1242 | Get Quote |
|
100MG | 1674 | Get Quote |
|
500MG | 3348 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSF5
-
NoteResearch use only, not for human use.
-
Brief DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.
-
DescriptionSF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.(In Vitro):SF5 shows strong cell survival effect of kidney epithelial cells (93% at a concentration of 2.5 μM).
-
SynonymsSF-5; SF 5; 2,2-Diphenylethylisothiocyanate
-
PathwayApoptosis
-
TargetApoptosis
-
Recptorribonucleotide reductase(RR);Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number34634-22-5
-
Formula Weight239.3
-
Molecular FormulaC15H13NS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C=NCC(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Larsen IK, et al. Caracemide, a site-specific irreversible inhibitor of protein R1 of Escherichia coli ribonucleotide reductase. J Biol Chem. 1992 Jun 25;267(18):12627-31.
molnova catalog
related products
-
JPH203
JPH203 (KYT-0353)is a potent, selective L-type amino acid transporter 1 (LAT1, SLC7A5) inhibitor with IC50 of 60 nM (leucine uptake inhibition).
-
Ecdysone
Ecdysone is a major steroid hormone in insects and herbs. Ecdysone triggers mineralocorticoid receptor activation and induces cellular apoptosis. Ecdysone signaling through Ecdysone receptor isoform B1 is required cell autonomously for the muscle death.
-
Pyrazoloacridine
Pyrazoloacridine is a nucleic acid binding agent that inhibits the activity of topo I and II with an IC50 of 1.25 μM in K562 cells. Pyrazoloacridine shows anti-cancer activity.